COST-EFFECTIVENESS OF WEARABLE CARDIOVERTER-DEFIBRILLATOR IN CHINA: A DECISION ANALYSIS

被引：0
|
作者：
Jiang, X. [1 ]
Ming, W. K. [2 ]
You, J. [1 ]
机构：
[1] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV33
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [21] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Anil-Martin Sinha
    Jens Bense
    Wolfgang Hohenforst-Schmidt
    Journal of Interventional Cardiac Electrophysiology, 2021, 62 : 401 - 407
  • [22] The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital
    Sinha, Anil-Martin
    Bense, Jens
    Hohenforst-Schmidt, Wolfgang
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 62 (02) : 401 - 407
  • [23] Tumescent local anesthesia versus general anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: A cost-effectiveness analysis
    Romero, Jorge
    Rodriguez-Taveras, Joan
    Diaz, Juan Carlos
    Lorente-Ros, Marta
    Braunstein, Eric D.
    Alviz, Isabella
    Parides, Michael
    Haroun, Magued W.
    Papa, Lauren
    Dave, Kartikeya
    Rodriguez, Daniel
    Krishnan, Suraj
    Toquica, Christian
    Velasco, Alejandro
    Gabr, Mohamed
    Natale, Andrea
    Di Biase, Luigi
    HEART RHYTHM, 2023, 20 (04) : 522 - 529
  • [24] Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis
    Zaca, Valerio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (10) : 597 - 605
  • [25] The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator
    Yao, Guiqing
    Freemantle, Nick
    Calvert, Melanie J.
    Bryan, Stirling
    Daubert, Jean-Claude
    Cleland, John G. F.
    EUROPEAN HEART JOURNAL, 2007, 28 (01) : 42 - 51
  • [26] Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator
    Daimee, Usama A.
    Vermilye, Katherine
    Moss, Arthur J.
    Goldenberg, Ilan
    Klein, Helmut U.
    McNitt, Scott
    Zareba, Wojciech
    Kutyifa, Valentina
    HEART RHYTHM, 2018, 15 (09) : 1379 - 1386
  • [27] COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFECT OF IMPROVED BATTERY LIFE AND COMPARISON WITH AMIODARONE THERAPY
    LARSEN, GC
    MANOLIS, AS
    SONNENBERG, FA
    BESHANSKY, JR
    ESTES, NAM
    PAUKER, SG
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) : 1323 - 1334
  • [28] Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
    Klein, Helmut U.
    Goldenberg, Ilan
    Moss, Arthur J.
    EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2230 - 2242
  • [29] Use of the wearable cardioverter-defibrillator - the Swiss experience
    Boldizsar, Kovacs
    Sven, Reek
    Christian, Sticherling
    Beat, Schaer
    Andre, Linka
    Peter, Ammann
    Roman, Brenner
    Nazmi, Krasniqi
    Andreas, Muller S.
    Omer, Dzemali
    Richard, Kobza
    Christian, Grebmer
    Laurent, Haegeli
    Jan, Berg
    Kurt, Mayer
    Jurg, Schlapfer
    Giulia, Domenichini
    Tobias, Reichlin
    Laurent, Roten
    Haran, Burri
    Urs, Eriksson
    Ardan, Saguner Ma
    Jan, Steffel
    Firat, Duru
    SWISS MEDICAL WEEKLY, 2020, 150 : w20343
  • [30] WEARABLE CARDIOVERTER-DEFIBRILLATOR - WHERE ARE THE CLINICAL GUIDELINES?
    Agarwal, M.
    Botta, V.
    Gardner, J.
    Khouzam, R.
    CARDIOLOGY, 2016, 134 : 277 - 277
12345